Circ-sh3rf3/GATA-4/miR-29a regulatory axis in fibroblast-myofibroblast differentiation and myocardial fibrosis.
Cai-Xia MaZhi-Ru WeiTong SunMing-Hui YangYu-Qie SunKun-Lun KaiJia-Chen ShiMeng-Jiao ZhouZi-Wei WangJing ChenWei LiTian-Qi WangShan-Feng ZhangLixiang XueMin ZhangQianqian YinMing-Xi ZangPublished in: Cellular and molecular life sciences : CMLS (2023)
The transdifferentiation from cardiac fibroblasts to myofibroblasts is an important event in the initiation of cardiac fibrosis. However, the underlying mechanism is not fully understood. Circ-sh3rf3 (circular RNA SH3 domain containing Ring Finger 3) is a novel circular RNA which was induced in hypertrophied ventricles by isoproterenol hydrochloride, and our work has established that it is a potential regulator in cardiac hypertrophy, but whether circ-sh3rf3 plays a role in cardiac fibrosis remains unclear, especially in the conversion of cardiac fibroblasts into myofibroblasts. Here, we found that circ-sh3rf3 was down-regulated in isoproterenol-treated rat cardiac fibroblasts and cardiomyocytes as well as during fibroblast differentiation into myofibroblasts. We further confirmed that circ-sh3rf3 could interact with GATA-4 proteins and reduce the expression of GATA-4, which in turn abolishes GATA-4 repression of miR-29a expression and thus up-regulates miR-29a expression, thereby inhibiting fibroblast-myofibroblast differentiation and myocardial fibrosis. Our work has established a novel Circ-sh3rf3/GATA-4/miR-29a regulatory cascade in fibroblast-myofibroblast differentiation and myocardial fibrosis, which provides a new therapeutic target for myocardial fibrosis.
Keyphrases
- transcription factor
- left ventricular
- long non coding rna
- poor prognosis
- cell proliferation
- long noncoding rna
- heart failure
- transforming growth factor
- liver fibrosis
- extracellular matrix
- signaling pathway
- binding protein
- oxidative stress
- atrial fibrillation
- pulmonary fibrosis
- climate change
- diabetic rats
- human health